Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The intestinal UGT1A8 and UGT1A10 enzymes were suggested to have a negative impact on the bioavailability of orally administered therapeutic drugs (Mizuma, 2009)
6d), which is designed to accept customized annotations
Researchers, particularly those engaged in Metabolic & Weight Research or even Mitochondrial Research initiatives, are increasingly exploring its potential
How Do You Use Each One in Practice
Wei-Dong Chen, [email protected] These authors have contributed equally to this work This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
US$ 20.52
US$ 27.73
US$ 28.96
